Well I think they have a point, though. A drug company goes through the expense of developing a few one-shot cures, if that's even possible, and then they go bankrupt. Maybe that's even the ethical thing to do, but then the remaining companies will be the ones that weren't willing to take that sacrifice. This might be where public funding should come in, because various cures besides the ethics of the thing should even benefit society as a whole financially.